A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors

Local Institution - 0039, Copenhagen

Local Institution - 0006, New York

Local Institution - 0045, Mineola

Local Institution - 0019, Milan

Local Institution - 0004, Baltimore

Local Institution - 0008, Durham

Local Institution - 0023, Madrid

Local Institution - 0017, Madrid

Local Institution - 0010, Madrid

Local Institution - 0003, Charlotte

Local Institution - 0001, Atlanta

Local Institution - 0046, Gainesville

Local Institution - 0036, Tampere

Local Institution - 0021, Tampa

Local Institution - 0050, Kassel

Local Institution - 0032, Padua

Local Institution - 0047, Muscle Shoals

Local Institution - 0011, Franklin

Local Institution - 0002, Nashville

Local Institution - 0024, Bologna

Local Institution - 0048, Bonn

Local Institution - 0026, Frankfurt

Local Institution - 0049, Omaha

Local Institution - 0016, Heidelberg

Local Institution - 0009, Houston

Local Institution - 0044, Aurora

Local Institution - 0020, Napoli

Local Institution - 0007, Portland

Local Institution - 0042, Seattle

Local Institution - 0015, New Haven

Local Institution - 0005, Boston

Local Institution - 0043, Boston

Local Institution - 0038, Toronto

Local Institution - 0014, Helsinki

Local Institution - 0037, Barcelona

Local Institution - 0018, London

Local Institution - 0012, Glasgow

Local Institution - 0013, Sutton